Drug Combination Shrinks Breast Cancer Metastases In Brain
 

Lapatinib (Tykerb) and capecitabine (Xeloda) were paired in an extension of a Phase 2 clinical trial in which lapatinib given alone shrank brain metastases significantly in six percent of 241 patients

To read full article: http://www.sciencedaily.com/releases...1216104315.htm